Aceragen
Durham
About Aceragen
Aceragen is a developer of therapeutic treatments intended for rare and ultra-rare diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $35.0M
- Funding stage: M&A
- Last round: Private Equity (May 2021)
- Website: aceragen.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/aceragen-33506 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.